2 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Dysphagia: new trials by email Literature Review of Dysphagia trials Research Report on Dysphagia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of 3% Sodium Chloride on Post-operative Dysphagia Following Anterior Cervical Spine Surgery 3% Sodium Chloride, Normal Saline - Dysphagia | Phase 1 | Withdrawn | University of Missouri-Columbia | 2018-04-01 | 2019-04-03 | |
| Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis dexlansoprazole - Gastroesophageal Reflux Disease, Eosinophilic Esophagitis | Phase 1 / Phase 2 | Withdrawn | Mayo Clinic | 2012-03-01 | 2012-04-19 |
Deglutition Disorders (2) · Eosinophilic Esophagitis (1) · Gastroesophageal Reflux (1)
Digestive System Diseases (2) · Esophageal Diseases (2) · Gastrointestinal Diseases (2) · Otorhinolaryngologic Diseases (2) · Pharyngeal Diseases (2) · Eosinophilia (1) · Esophageal Motility Disorders (1) · Esophagitis (1) · Gastroenteritis (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Leukocyte Disorders (1)
Dexlansoprazole (1) · Saline Solution (1) · Sodium Chloride (1)
Mayo Clinic (1) · University of Missouri-Columbia (1)
Jeffrey A Alexander, MD (1) · Tomoko Tanaka, MD (1)